Scarica l'app Stockscreener
114.92
0.67%
-0.78
Dopo l'orario di chiusura:
114.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CORT Giù?
Forum
Previsione
Precedente Chiudi:
$115.70
Aprire:
$114.42
Volume 24 ore:
676.00K
Relative Volume:
0.64
Capitalizzazione di mercato:
$12.42B
Reddito:
$769.10M
Utile/perdita netta:
$46.67M
Rapporto P/E:
328.34
EPS:
0.35
Flusso di cassa netto:
$119.79M
1 W Prestazione:
+1.88%
1M Prestazione:
+0.60%
6M Prestazione:
+242.64%
1 anno Prestazione:
+60.46%
Intervallo 1D:
$113.20
$116.99
Intervallo di 1 settimana:
$108.25
$117.50
Portata 52W:
$28.66
$126.38
Corcept Therapeutics Inc Stock (CORT) Company Profile
Nome
Corcept Therapeutics Inc
Settore
Industria
Telefono
650.688.8803
Indirizzo
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
114.92 | 12.51B | 769.10M | 46.67M | 119.79M | 0.35 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-05-13 | Aggiornamento | UBS | Neutral → Buy |
| 2026-03-26 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-12-31 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2025-12-16 | Iniziato | UBS | Neutral |
| 2025-11-18 | Iniziato | Wolfe Research | Peer Perform |
| 2023-11-06 | Aggiornamento | Truist | Hold → Buy |
| 2023-04-11 | Iniziato | SVB Securities | Market Perform |
| 2023-04-04 | Iniziato | Piper Sandler | Overweight |
| 2023-02-15 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-01 | Downgrade | Truist | Buy → Hold |
| 2022-07-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-06-27 | Ripresa | Canaccord Genuity | Buy |
| 2022-02-02 | Iniziato | Canaccord Genuity | Buy |
| 2022-01-28 | Iniziato | Truist | Buy |
| 2020-08-05 | Downgrade | Jefferies | Buy → Hold |
| 2019-09-24 | Iniziato | Jefferies | Buy |
| 2019-09-06 | Iniziato | H.C. Wainwright | Buy |
| 2019-02-04 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | Reiterato | Stifel | Hold |
| 2018-05-31 | Downgrade | Stifel | Buy → Hold |
| 2018-03-09 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | Iniziato | Stifel | Buy |
| 2017-02-02 | Iniziato | Ladenburg Thalmann | Buy |
| 2015-04-21 | Iniziato | FBR Capital | Outperform |
| 2014-01-13 | Downgrade | Stifel | Buy → Hold |
| 2013-08-09 | Downgrade | Janney | Buy → Neutral |
| 2013-08-09 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | Reiterato | JMP Securities | Mkt Outperform |
| 2010-01-06 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | Iniziato | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | Aggiornamento | Punk, Ziegel & Co | Mkt Perform → Accumulate |
Mostra tutto
Corcept Therapeutics Inc Borsa (CORT) Ultime notizie
Corcept president Sean Maduck sells $2.86m in stock By Investing.com - Investing.com South Africa
Corcept Therapeutics Insider Sold Shares Worth $2,860,737, According to a Recent SEC Filing - marketscreener.com
Corcept Therapeutics Insider Sold Shares Worth $6,460,766, According to a Recent SEC Filing - marketscreener.com
Corcept Therapeutics oncology president sells $6.46m in shares By Investing.com - Investing.com South Africa
Corcept president Sean Maduck sells $2.86m in stock - Investing.com
Corcept Therapeutics oncology president sells $6.46m in shares - Investing.com
Corcept Therapeutics (CORT) CFO adds shares via plan and restricted awards - Stock Titan
Corcept (CORT) oncology president reports shares and 480K options - Stock Titan
CORCEPT Therapeutics Officer Vieira Roberto Wandenkolk to Sell 75,295 Shares Including 74,999 Stock Options (NASDAQ: CORT) - Kalkine Media
$8.3M stock sale planned at Corcept (NASDAQ: CORT) - Stock Titan
QQQ Stock Price TodayGet QQQ News, Analysis and Trading Ideas - Stocktwits
Why Is Corcept (CORT) Down 1.2% Since Last Earnings Report? - Yahoo Finance
Corcept Therapeutics(CORT.US) Officer Sells US$3.89 Million in Common Stock - Moomoo
Corcept (NASDAQ: CORT) director to sell 26,685 shares - Stock Titan
$22M stock sale lined up at Corcept Therapeutics (NASDAQ: CORT) - Stock Titan
Corcept Therapeutics Stock 6-Day Winning Spree: Stock Climbs 11% - Trefis
Corcept Therapeutics stock hits all-time high at 122.5 USD By Investing.com - Investing.com Canada
Corcept Therapeutics(CORT.US) Director Sells US$12.25 Million in Common Stock - Moomoo
Corcept Therapeutics rated Strong Buy with 44% revenue growth and key FDA decisions ahead - Pluang
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Corcept (NASDAQ:CORT) - Yahoo Finance
Zacks Research Has Bullish Forecast for CORT Q3 Earnings - MarketBeat
CORT Stock Slips After-Hours On Weak Q4 Print: Retail Is Watching April FDA Meeting For Relacorilant As Next Catalyst - Stocktwits
Truist Financial Initiates Corcept Therapeutics(CORT.US) With Buy Rating, Announces Target Price $164 - Moomoo
Corcept Therapeutics (NASDAQ:CORT) Director James Wilson Sells 10,000 Shares of Stock - MarketBeat
Corcept (NASDAQ: CORT) exec sells 10,000 shares at $116 - Stock Titan
Corcept (NASDAQ: CORT) director sells 10,000 shares under 10b5-1 plan - Stock Titan
Corcept (NASDAQ: CORT) director plans open-market sale of 103,606 shares - Stock Titan
Truist Adjusts Price Target on Corcept Therapeutics to $164 From $50, Maintains Buy Rating - marketscreener.com
Truist assumes Corcept Therapeutics stock with buy rating on Cushing’s opportunity - Investing.com Nigeria
CORCEPT THERAPEUTICS INC SEC Filing (Aug 17, 2026) - Stock Titan
CORT Looks 65.7% Overvalued on GF Value™ - GuruFocus
Corcept, Revolution Medicines lead ten large-cap healthcare stocks surging in 2026 (XLV:NYSEARCA) - Seeking Alpha
23,257 Shares in Corcept Therapeutics Incorporated $CORT Purchased by GSA Capital Partners LLP - MarketBeat
Corcept therapeutics chief development officer sells $1.8m in stock - Investing.com
Corcept therapeutics chief development officer sells $1.8m in stock By Investing.com - Investing.com Canada
Corcept Therapeutics (CORT) CBO reports 17,530-share stock gifts and trust holdings - Stock Titan
Renaissance Technologies (CORT) discloses 4.90% beneficial stake in Corcept Therapeutics - Stock Titan
Corcept Therapeutics Incorporat (CORT) Stock Forecasts - Yahoo Finance
Sean Maduck Sells 1,031 Shares of Corcept Therapeutics (NASDAQ:CORT) Stock - MarketBeat
William Guyer Sells 16,300 Shares of Corcept Therapeutics (NASDAQ:CORT) Stock - MarketBeat
Corcept chief development officer sells $418,561 of stock By Investing.com - Investing.com Nigeria
Corcept chief development officer sells $418,561 of stock - Investing.com
Sei Investments Co. Sells 62,377 Shares of Corcept Therapeutics Incorporated $CORT - marketbeat.com
Amundi Acquires New Shares in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline (PR Newswire) - Aktiellt
California State Teachers Retirement System Boosts Stake in Corcept Therapeutics Incorporated $CORT - marketbeat.com
12,478 Shares in Corcept Therapeutics Incorporated $CORT Purchased by Evanson Financial LLC - MarketBeat
Corcept Therapeutics Incorporat (CORT) Stock forecasts - Yahoo Finance UK
Corcept Therapeutics (CORT) Stock May Trade At A Discount Yet A Premium On Sales - Yahoo Finance
Corcept CDO William Guyer sells $418,561 in common stock By Investing.com - Investing.com South Africa
Corcept CDO William Guyer sells $418,561 in common stock - Investing.com
Corcept Therapeutics Inc Azioni (CORT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):